블로그

TPN

Metabolic Complications of TPN

Healthcare professional assisting patient with setting up TPN

TPN, also known as total parenteral nutrition, is an intravenous drug therapy used for people with a compromised digestive system (gastrointestinal tract) or who are unable to consume food orally. TPN contains a mixture of various components to fulfill the nutritional or dietary needs of a person, including carbohydrates, protein, fat, vitamins, minerals, and other trace elements. 

IV Fluids Fully in Stock

Consistent availability, uninterrupted care
시작하기

Undoubtedly, TPN is a lifesaving therapy that delivers nutrients directly to the bloodstream. But as the method of food intake and the process of metabolism is suddenly changed through TPN, the body can exhibit some complications in response to change. TPN therapy should be used for the shortest duration possible and the switch to enteral (oral, feeding tube) therapy should be made as soon as a patient is able. In this blog, we will discuss the 4 most common metabolic complications that can arise with TPN, and how you can address or prevent them. 

What Is Meant By Metabolic Complications and Why They Occur

Metabolism is the chemical reaction that takes place in our body to convert the nutrients present in our food into energy. When the normal metabolic pathway of our body is disturbed due to any reason, like during disease, treatment, drug therapy, or any other external factors, it may cause complications, which are commonly referred to as metabolic complications.

Metabolic complications commonly involve imbalances or disturbances in the levels of electrolytes, hormones, nutrients, and other substances that are needed for various bodily functions. These imbalances can lead to metabolic complications, like hyperglycemia, liver dysfunction, refeeding syndrome, and electrolyte imbalances.

Top 4 Metabolic Complications of TPN And How To Prevent Them

The 4 most common metabolic complications of TPN are:

Hyperglycemia (high blood glucose)  

Scientist hold a sample tube of Glucose test to measure TPN metabolic complications.

Total parenteral nutrition is commonly formulated according to the patient’s individual needs. As TPN solutions contain glucose, total parenteral formulations with higher amounts of glucose can increase the blood sugar levels of the patient, leading to hyperglycemia.

To prevent or reduce the risks of hyperglycemia,  blood glucose monitoring during TPN therapy and the use of formulations with lower to moderate amounts of glucose are crucial. If hyperglycemia does occur from TPN use, it can be treated with certain medications, such as insulin, to reduce blood glucose levels. Additionally, careful monitoring of sugar levels is necessary for patients until complete recovery.

Electrolyte Imbalance

Another metabolic complication and major concern associated with TPN use is electrolyte imbalance. TPN administration can disturb the levels of electrolytes in the body, like calcium, sodium, magnesium, and potassium, which can lead to further complications, such as arrhythmias, neuromuscular dysfunction, and others.

The prevention of electrolyte imbalance requires close assessment of electrolyte levels, regular monitoring, and dose or formulation adjustments according to the patient’s condition with the collaboration of doctors, pharmacists, and nutritionists.

전문가와 상담하세요

공제금 지원에 관하여
상담 일정을 잡으세요

Refeeding Syndrome 

Refeeding syndrome is a metabolic condition that occurs when a severely nutrient-deprived or malnourished patient receives excessive nutrition rapidly, like in TPN or other forms of dietary therapy. Refeeding syndrome causes electrolyte imbalances and vitamin deficiencies and can also lead to seizures, coma, or even death.

Hence, to prevent refeeding syndrome, it is crucial to adopt a gradual approach to nutritional therapy, mainly in severely nutrient-deprived or malnourished patients, as well as people who have undergone extreme dieting or starvation. Before administering TPN, the doctor or pharmacist must ask about the health history of the patient to prevent such occurrences from happening.

Liver Dysfunction 

Liver dysfunction from TPN can occur as a result of fat (lipid) imbalance and excessive infusion of glucose or lipids, which can compromise the liver functions of the patient.

To reduce the risks of TPN-related liver dysfunction, healthcare providers minimize excessive administration and formulation of lipids and glucose in TPN therapy as well as carefully monitor liver levels to ensure no damage is being done. A switch to an enteral nutrition approach will help to decrease the risk of liver dysfunction in patients.

이 정보는 의학적 조언이나 치료를 대체할 수 없습니다. 새로운 치료를 시작하기 전에 담당 의사 또는 의료 서비스 제공자와 건강 상태에 대해 상담하십시오. AmeriPharma® Specialty Care는 제공된 정보 또는 그 결과로 내려진 진단이나 치료에 대해 어떠한 책임도 지지 않으며, 콘텐츠의 신뢰성에 대해서도 책임을 지지 않습니다. AmeriPharma® Specialty Care는 여기에 나열된 모든 웹사이트/기관을 운영하는 것은 아니며, 해당 콘텐츠의 가용성이나 신뢰성에 대해서도 책임을 지지 않습니다. 이러한 목록은 AmeriPharma® Specialty Care의 보증, 후원 또는 추천을 암시하거나 구성하지 않습니다. 이 웹페이지에는 AmeriPharma® Specialty Care와 제휴하지 않은 제약 회사의 상표 또는 등록 상표인 브랜드 처방약에 대한 참조가 포함될 수 있습니다.
의학적으로 검토됨 Samantha Kaeberlein 박사, 약학박사

사만다 케버리인 약학박사는 오하이오주 캔턴에서 태어나고 자랐습니다. 2020년 노스이스트 오하이오 의과대학(NEOMED)에서 약학 학위를 받았습니다. 그녀의 직업에서 가장 보람 있는 부분은 환자들이 자신의 건강 관리에 대해 정보에 기반하고 균형 잡힌 결정을 내릴 수 있도록 의료 지침을 제공하는 것입니다. 그녀의 전문 분야는 노인 의학 및 장기 요양입니다. 여가 시간에는 야외 활동, 독서, 그리고 미국 최고의 커피를 찾는 것을 즐깁니다.

문의하기

아래 HIPAA 규격 양식을 사용하여 처방전 재조제를 요청하세요. 복용 중인 약이나 복용 방법에 대한 문의 사항이 있으시면 문의하기 페이지를 방문하시거나 다음 번호로 전화해 주세요. (877) 778-0318.

HIPAA Compliant

제출하면 AmeriPharma에 동의하는 것입니다. 이용 약관, 개인정보 보호정책, 그리고 개인정보 보호 관행 고지

ko_KRKorean